Kaplan-Meier OS survival analysis for FAM83A in BLCA, CESC, HNSC, LUAD, LUSC, and PAAD showed that FAM83A was a positive risk factor for LUAD, LUSC, and PAAD patients (Figures 2A–C). This evidence concerns the gene SACK1A and pancreatic adenocarcinoma.